Evidence map›Paper›PMID 23775230›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2013

Visualizing CaMKII and CaM activity: a paradigm of compartmentalized signaling.

Julie Bossuyt, Donald M Bers

Abstract readReview
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. NMDA Receptors: Next therapeutic targets for Tinnitus?Biochemistry and biophysics reports · 2025
    Review
  2. Article
  3. CaThe Journal of biological chemistry · 2020
    Article
  4. Review
  5. TRP Channels Regulation of Rho GTPases in Brain Context and Diseases.Frontiers in cell and developmental biology · 2020
    Review
  6. Article
  7. Review
  8. Differential Regulation of PI(4,5)PFrontiers in molecular neuroscience · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Julie BossuytDepartment of Pharmacology, University of California, Davis, Genome Building, Rm 3503, Davis, CA 95616-8636, USA. jbossuyt@ucdavis.edu
Donald M Bers

Funding

Program AdministrationP01HL080101 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2006 to 2015
$23.4M
IONIC CONTROL OF CARDIAC MUSCLE CONTRACTION: EC COUPLINGR37HL030077 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2005 to 2014
$3.9M
Multi-scale Systems Model of Murine Heart FailureR01HL105242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERS, DONALD M, MCCULLOCH, ANDREW D. · 2012 to 2016
$3.5M
The regulation and role of PKD in the heartR01HL103933 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOSSUYT, JULIE B · 2010 to 2014
$1.9M
NHLBI NIH HHS P01 HL080101NHLBI NIH HHS P01-HL080101NHLBI NIH HHS R01 HL103933NHLBI NIH HHS R01 HL105242NHLBI NIH HHS R37 HL030077NHLBI NIH HHS R37-HL30077PHS HHS R01-130933
6 · The paper itself

Abstract

Calcium (Ca(2+)) has long been recognized as a crucial intracellular messenger attaining stimuli-specific cellular outcomes via localized signaling. Ca(2+)-binding proteins, such as calmodulin (CaM), and its target proteins are key to the segregation and refinement of these Ca(2+)-dependent signaling events. This review not only summarizes the recent technological advances enabling the study of subcellular Ca(2+)-CaM and Ca(2+)-CaM-dependent protein kinase (CaMKII) signaling events but also highlights the outstanding challenges in the field.

Indexed as

AnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCalmodulinHumansCalcium-Calmodulin-Dependent Protein Kinase Type 2Calmodulin

Identifiers

PMID23775230
PMCPMC3962229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.